Product
ProCellics is the first-ever Raman spectroscopy system that can be used as a PAT (Process Analytical Technology) tool for the biopharmaceutical industry. ProCellics was developed exclusively for the in-line process control of critical nutrients and metabolites to ensure that cell cultures develop optimally. Raman spectroscopy has recently been confirmed by major pharmaceutical companies as a very effective bioprocess control tool. Resolution Spectra Systems now offers a GMP testing system that biotech companies can easily implement as an industrial-grade sensor to improve bioprocess development and in-line process control. The product delivers a number of major benefits to users: * A better understanding of bioprocesses * Improved yields and a lower reject batch rate * More effective final-product quality control * Regulatory complianceL'histoire du produit
ProCellics was developed as a result of the ANAgRAM project (2013-2016, 9 partners, 4.9 million euros invested) led by Resolution Spectra Systems. The purpose of the ANAgRAM project was to develop high-performance, ultra-integrated Raman spectroscopy solutions to deliver non-destructive testing capabilities for industrial process control, microbiological analysis, in situ environmental testing, and anti-counterfeiting systems. The project partners: Resolution Spectra Systems, Pyxalis, Teem Photonics, ATT, Leti, IPAG, IMEP-LAHC, LEPMI, and LTM.
Investissement
6 million euros
Délai de mise sur le marché
3 years
La société : Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Our comprehensive life science portfolio supports biologics manufacturers during all stages of drug production. We offer a broad range of products and services designed to meet the diverse needs of different applications including single-use manufacturing, filtration, chromatography, raw materials, engineering and validation services.
Year founded
2011